Company Profile

Tissue Genetics Inc
Profile last edited on: 3/25/13      CAGE: 47TZ8      UEI:

Business Identifier: molecular diagnostic testing for Hereditary (genetic) diseases
Year Founded
2005
First Award
2007
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

14991 East Hampden Avenue Suite 168
Aurora, CO 80014
   (720) 364-1990
   tissue_genetics_inc@yahoo.com
   www.tissuegenetics.com
Location: Single
Congr. District: 06
County: Arapahoe

Public Profile

Tissue Genetics Inc. is a molecular diagnostics company with technology for improving the diagnosis, treatment and prevention of genetic diseases. The firm's proprietary biomarkers and novel test methods allow clinicians to diagnose genetic diseases fast, easily, accurately and economically. The objective is to establish a new paradigm for screening of genetic diseases, providing critical information for determining the patients’ optimum course of care. The firm's diagnostic tests include proprietary, monoclonal antibodies for immunohistochemistry (IHC) screening to visualize the protein product of the gene, specifically to detect a protein truncation

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 2 NIH $962,126
Project Title: Ihc Test For Brca1 Hereditary Ovarian Cancer
2010 2 NIH $768,658
Project Title: BRCA2 Hereditary Ovarian Cancer Tissue Truncation Test
2008 1 NIH $149,043
Project Title: PARP Inhibitor Targeted Therapy for Breast Cancer
2007 1 NIH $54,849
Project Title: Development of a BRCA Breast Cancer Diagnostic Test

Key People / Management

  Kimberly Gibson -- Chief Executive Officer

  Jeffrey T Holt -- Chief Scientific Officer

Company News

There are no news available.